Heart Surgery Medication Management.
Medication management before and after cardiac surgery is a critical but often confusing aspect of surgical preparation. Patients facing cardiac surgery are typically on multiple cardiovascular medications, and the question of which to continue, which to stop, and when to restart requires careful coordination between the cardiologist, cardiac surgeon, anesthesiologist, and primary care physician. Errors in perioperative medication management — particularly with anticoagulants and antiplatelet agents — can cause life-threatening bleeding or thrombotic complications. The most common medication categories requiring adjustment include: anticoagulants (warfarin, direct oral anticoagulants), antiplatelet agents (aspirin, clopidogrel, ticagrelor), antihypertensives (ACE inhibitors, ARBs, beta-blockers), diabetes medications (insulin, metformin, SGLT2 inhibitors), and herbal supplements and over-the-counter medications that affect bleeding. Each category has specific evidence-based timing for discontinuation and resumption. After surgery, patients leave the hospital on a new medication regimen that typically includes aspirin, beta-blockers, statins, and often temporary anticoagulation. Understanding each medication's purpose, expected duration, and potential side effects empowers patients to manage their regimen effectively and report concerning symptoms promptly.
What the evidence shows.
Evidence-based medication timing for cardiac surgery: WARFARIN: stop 5 days before surgery (INR goal below 1.5 on day of surgery); bridging with heparin is indicated for mechanical heart valves, recent DVT/PE, or atrial fibrillation with high CHADS2 score. DIRECT ORAL ANTICOAGULANTS (rivaroxaban, apixaban, dabigatran): stop 2-3 days before surgery (3 days if renal impairment); no bridging needed. CLOPIDOGREL (Plavix): stop 5-7 days before surgery per ACC/AHA guidelines; this is the most common cause of surgical bleeding when not adequately held. TICAGRELOR (Brilinta): stop 5 days before surgery. ASPIRIN: CONTINUE through surgery for CABG (Class I recommendation — improves graft patency); for valve surgery, institutional protocols vary but most continue aspirin. METFORMIN: stop 24-48 hours before surgery to prevent lactic acidosis with contrast dye and renal impairment; restart when kidney function and oral intake normalize. ACE INHIBITORS/ARBs: hold on the morning of surgery (risk of refractory hypotension during anesthesia); restart postoperatively when blood pressure stabilizes. BETA-BLOCKERS: continue through surgery (abrupt cessation can trigger rebound tachycardia and ischemia). STATINS: continue through surgery (anti-inflammatory and plaque-stabilizing effects are beneficial perioperatively). SGLT2 INHIBITORS (empagliflozin, dapagliflozin): stop 3-4 days before surgery (risk of euglycemic diabetic ketoacidosis).
Current recommendations.
Perioperative medication management protocol: PREOPERATIVE STOPS: (1) Warfarin: 5 days before, with bridging as indicated; (2) DOACs: 2-3 days before; (3) Clopidogrel: 5-7 days before; (4) Ticagrelor: 5 days before; (5) Metformin: 24-48 hours before; (6) ACE inhibitors/ARBs: morning of surgery; (7) SGLT2 inhibitors: 3-4 days before; (8) Herbal supplements (fish oil, garlic, ginkgo, vitamin E): 7-10 days before. CONTINUE THROUGH SURGERY: aspirin (for CABG), beta-blockers, statins, thyroid medications, anti-seizure medications, inhaled bronchodilators. POSTOPERATIVE NEW MEDICATIONS typically include: aspirin (indefinitely for CABG, 3-6 months for bioprosthetic valve), beta-blocker (rate control, long-term benefit), statin (regardless of cholesterol level), proton pump inhibitor (short-term for GI protection), and anticoagulation (warfarin for mechanical valve or AF, duration varies). KEY SAFETY RULE: never stop or change cardiac medications without consulting your surgical team — abrupt discontinuation of beta-blockers or antianginal medications can precipitate cardiac events.
Why this matters for your decision.
Medication errors in the perioperative period are one of the most common preventable causes of cardiac surgery complications. A second opinion that includes medication review can identify potential interactions, ensure appropriate timing of anticoagulant and antiplatelet cessation, and verify that the postoperative medication plan is optimized for the specific procedure and patient profile. This is particularly important for patients on complex multi-drug regimens or those seeing multiple specialists who may not communicate effectively about medication changes.
Need help with this decision?
Our Heart Team evaluates your specific situation with AI-augmented analysis and dual-physician review.